MedPath

深圳市天道医药有限公司

Ownership
-
Established
2004-06-29
Employees
-
Market Cap
-
Website
https://techdow.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

NMPA:6

Drug Approvals

Enoxaparin Sodium

Product Name
依诺肝素钠
Approval Number
国药准字H20056845
Approval Date
Aug 27, 2020
NMPA

Enoxaparin Sodium Injection

Product Name
依诺肝素钠注射液
Approval Number
国药准字H20056848
Approval Date
Dec 5, 2019
NMPA

Enoxaparin Sodium Injection

Product Name
依诺肝素钠注射液
Approval Number
国药准字H20056850
Approval Date
Dec 5, 2019
NMPA

Enoxaparin Sodium Injection

Product Name
依诺肝素钠注射液
Approval Number
国药准字H20056849
Approval Date
Dec 5, 2019
NMPA

Enoxaparin Sodium Injection

Product Name
依诺肝素钠注射液
Approval Number
国药准字H20056846
Approval Date
Dec 5, 2019
NMPA

Enoxaparin Sodium Injection

Product Name
依诺肝素钠注射液
Approval Number
国药准字H20056847
Approval Date
Dec 5, 2019
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath